Brain Sci 11(7):831
doi:10.1056/NEJMoa2301972 Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, O'Farrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z
But GLP-1 medications do much more than blunt appetite
5 Hunter GR, Plaisance EP, Fisher G
Start your intake How GLP-1 Medications Influence Triglyceride Levels GLP-1 agonists lower triglycerides through multiple metabolic pathways: enhanced insulin sensitivity, reduced hepatic triglyceride production, and improved lipid clearance
These critical effects are mediated through GLP-1R signaling within the mesolimbic reward system, which directly targets key drivers of AUD, ALD, and MetALD